Bone Graft Materials Observational Registry (APPROACH-001)

April 4, 2017 updated by: Baxter Healthcare Corporation

A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice

A multi-center, prospective, observational patient registry to collect information on the clinical outcomes and "real world" use of approved and commercially available bone graft substitutes, autograft and allograft.

Study Overview

Study Type

Observational

Enrollment (Actual)

329

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Budapest, Hungary
        • Buda Health Center
    • Zwolle
      • Groot Wezenland, Zwolle, Netherlands, 8011 JW
        • Isala Klinieken
    • California
      • San Francisco, California, United States, 94143
        • UCSF
    • Georgia
      • Atlanta, Georgia, United States, 30342
        • St. Joseph's Hospital - Resurgeons Orthopedics
      • Carrollton, Georgia, United States, 30117
        • Carrollton Orthopedics
    • Kentucky
      • Lexington, Kentucky, United States, 40509
        • Bluegrass Orthopedics & Hand Care Research
    • Massachusetts
      • Worcester, Massachusetts, United States, 01605
        • Arthritis & Joint Center - U. Mass. Memorial
    • Michigan
      • Southfield, Michigan, United States, 48072
        • PRESSD
      • West Bloomfield, Michigan, United States, 48322
        • Henry Ford West Bloomfield Hospital
    • Montana
      • Missoula, Montana, United States, 59802
        • Montana Neuroscience Institute Foundation
    • Nevada
      • Las Vegas, Nevada, United States, 89144
        • Physicians Research Options Spine Center
    • New York
      • Syracuse, New York, United States, 13215
        • Syracuse Orthopedic Specialists
    • Tennessee
      • Nashville, Tennessee, United States, 37203
        • Neurosurgical Associates
    • Texas
      • Plano, Texas, United States, 75093
        • Brain & Spine of Texas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients enrolled in this study will be identified from the surgeon's medical practice and will include patients who failed conservative care and have been identified as requiring spinal fusion surgery.

Description

Inclusion Criteria:

  • The patient has failed conservative treatment and is a candidate for spinal fusion surgery.
  • The patient is ≥18 years old and of legal age of consent.
  • The patient is, in the investigator's opinion, psychosocially, mentally, and physically able to fully comply with this protocol, including the post-operative regimen, required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent.
  • The patient is skeletally mature (epiphyses closed).
  • The patient has signed the IRB approved informed consent.
  • The patient is willing and able to participate in post-operative clinical and radiographic follow up evaluations for 2 years.

Exclusion Criteria:

  • Patient has systemic infection or infection at the surgical site.
  • Patient has a medical condition that would interfere with post-operative assessments and care (i.e., neuromuscular disease, psychiatric disease, paraplegia, quadriplegia, etc.).
  • Patient is in poor general health or any concurrent disease process that would place the patient in excessive risk to surgery (i.e., significant circulatory or pulmonary problems, or cardiac disease).
  • Patient has a history (present or past) of substance abuse (recreational drugs, prescription drugs or alcohol) that in the investigator's opinion may interfere with protocol assessments and/or with the patient's ability to complete the protocol required follow-up.
  • The patient is pregnant/breastfeeding at the time of enrollment, or plans to become pregnant during the course of the study.
  • Patient is participating in another investigational study, which could confound results.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Spinal Fusion
Patients who undergo a planned spinal fusion procedure requiring approved bone grafting materials (e.g., bone grft substitutes, allograft or autograft).
spine fusion surgery utilizing any commercially available bone graft substitute(s), autograft or allograft
Other Names:
  • Autograft
  • Allograft/DBM
  • Ceramics
  • Synthetics
  • BMP
  • Messenchymal stem cell therapies

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Evidence of successful radiographic fusion
Time Frame: 6 months, 12 months & 24 months
6 months, 12 months & 24 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Maintenance or improvement in neurological status, as compared to baseline scores
Time Frame: 6 months 12 months & 24 months
6 months 12 months & 24 months
Improvement of pain/function in comparison to pre-operative QOL scores
Time Frame: 6 months, 12 months & 24 months
6 months, 12 months & 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Huub Kreuwel, Ph.D, Director of Medical Affairs

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (ACTUAL)

January 1, 2013

Study Completion (ACTUAL)

November 1, 2013

Study Registration Dates

First Submitted

September 8, 2009

First Submitted That Met QC Criteria

September 9, 2009

First Posted (ESTIMATE)

September 10, 2009

Study Record Updates

Last Update Posted (ACTUAL)

April 5, 2017

Last Update Submitted That Met QC Criteria

April 4, 2017

Last Verified

April 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe